Plasma homocysteine level is associated with the Expanded Disability Status Scale in neuromyelitis optica spectrum disorder
Neuroimmunomodulation Nov 28, 2019
Liang J, Liu J, Fan R, et al. - By analyzing case data obtained from 97 acute-phase neuromyelitis optica spectrum disorder (NMOSD) patients and 39 stable-phase NMOSD patients, researchers analyzed alterations in plasma homocysteine (Hcy) levels and examined the link between Hcy levels and inflammatory/immune/cerebrospinal fluid parameters in patients with NMOSD. They categorized the patients in the acute phase into 2 groups depending on the EDSS score with cutoff equal to 4. They found that acute-phase and stable-phase NMOSD patients did not significantly differ in terms of Hcy levels. Acute-phase NMOSD patients with EDSS score ≥ 4 exhibited significantly higher Hcy and erythrocyte sedimentation rate (ESR) levels. Besides, a positive correlation of EDSS with Hcy level, ESR, 1/aquaporin-4 titer, as well as a negative correlation of Hcy level with IgM was observed in acute-phase NMOSD patients. The potential of elevated plasma Hcy to influence the pathogenesis or progression of NMOSD was suggested based on these findings.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries